ARROWHEAD PHARMACEUTICALS, INC. Revenues
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Revenues of $11.26 million for the 3-month period ending 2018-09-30, per its 10-K filed 2018-12-11.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2018-12-11
- ARROWHEAD PHARMACEUTICALS, INC. revenues for the quarter ending 2018-09-30 was $11.26M, a 29.16% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. revenues for the quarter ending 2018-06-30 was $727.38K, a 92.21% decline year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. revenues for the quarter ending 2018-03-31 was $650.13K, a 92.77% decline year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. revenues for the quarter ending 2017-12-31 was $3.51M, a 19.60% decline year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. revenues for fiscal 2018 was $16.14M, a 48.60% decline from fiscal 2017.
- ARROWHEAD PHARMACEUTICALS, INC. revenues for fiscal 2017 was $31.41M, a 19736.49% increase from fiscal 2016.
- ARROWHEAD PHARMACEUTICALS, INC. revenues for fiscal 2016 was $158.33K, a 58.55% decline from fiscal 2015.
- ARROWHEAD PHARMACEUTICALS, INC. revenues for fiscal 2015 was $382.00K, a 118.29% increase from fiscal 2014.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month | Revenues 98 month | Revenues 101 month | Revenues 104 month | Revenues 107 month | Revenues 110 month | Revenues 113 month | Revenues 116 month | Revenues 119 month | Revenues 122 month | Revenues 125 month | Revenues 128 month | Revenues 131 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-09-30 | $11.26M 10-K · filed 2018-12-11 | $11.98M derived: sum of 2 quarters · filed 2018-12-11 | $12.63M derived: sum of 3 quarters · filed 2018-12-11 | $16.14M 10-K · filed 2018-12-11 | ||||||||||||
| 2018-06-30 | $727.38K 10-K · filed 2018-12-11 | $1.38M derived: sum of 2 quarters · filed 2018-12-11 | $4.89M 10-Q · filed 2018-08-07 | $13.60M derived: sum of 4 quarters · filed 2018-12-11 | ||||||||||||
| 2018-03-31 | $650.13K 10-K · filed 2018-12-11 | $4.16M 10-Q · filed 2018-05-08 | $12.87M derived: sum of 3 quarters · filed 2018-12-11 | $22.22M derived: sum of 4 quarters · filed 2018-12-11 | ||||||||||||
| 2017-12-31 | $3.51M 10-K · filed 2018-12-11 | $12.22M derived: sum of 2 quarters · filed 2018-12-11 | $21.57M derived: sum of 3 quarters · filed 2018-12-11 | $30.55M derived: sum of 4 quarters · filed 2018-12-11 | ||||||||||||
| 2017-09-30 | $8.71M 10-K · filed 2018-12-11 | $18.06M derived: sum of 2 quarters · filed 2018-12-11 | $27.04M derived: sum of 3 quarters · filed 2018-12-11 | $31.41M 10-K · filed 2018-12-11 | ||||||||||||
| 2017-06-30 | $9.34M 10-K · filed 2018-12-11 | $18.33M derived: sum of 2 quarters · filed 2018-12-11 | $22.69M 10-Q · filed 2018-08-07 | $22.73M derived: sum of 4 quarters · filed 2018-12-11 | ||||||||||||
| 2017-03-31 | $8.99M 10-K · filed 2018-12-11 | $13.35M 10-Q · filed 2018-05-08 | $13.38M derived: sum of 3 quarters · filed 2018-12-11 | $13.42M derived: sum of 4 quarters · filed 2018-12-11 | ||||||||||||
| 2016-12-31 | $4.37M 10-K · filed 2018-12-11 | $4.40M derived: sum of 2 quarters · filed 2018-12-11 | $4.44M derived: sum of 3 quarters · filed 2018-12-11 | $4.48M derived: sum of 4 quarters · filed 2018-12-11 | ||||||||||||
| 2016-09-30 | $31.25K 10-K · filed 2017-12-12 | $70.83K derived: sum of 2 quarters · filed 2017-12-12 | $114.58K derived: sum of 3 quarters · filed 2017-12-12 | $158.33K 10-K · filed 2018-12-11 | ||||||||||||
| 2016-06-30 | $39.58K 10-K · filed 2017-12-12 | $83.33K derived: sum of 2 quarters · filed 2017-12-12 | $127.08K 10-Q · filed 2017-08-03 | $170.83K derived: sum of 4 quarters · filed 2017-12-12 | ||||||||||||
| 2016-03-31 | $43.75K 10-K · filed 2017-12-12 | $87.50K 10-Q · filed 2017-05-03 | $131.25K derived: sum of 3 quarters · filed 2017-12-12 | $255.00K derived: sum of 4 quarters · filed 2017-12-12 | ||||||||||||
| 2015-12-31 | $43.75K 10-K · filed 2017-12-12 | $87.50K derived: sum of 2 quarters · filed 2017-12-12 | $211.25K derived: sum of 3 quarters · filed 2017-12-12 | $255.00K derived: sum of 4 quarters · filed 2017-12-12 | ||||||||||||
| 2015-09-30 | $43.75K 10-K · filed 2016-12-14 | $167.50K derived: sum of 2 quarters · filed 2016-12-14 | $211.25K derived: sum of 3 quarters · filed 2016-12-14 | $382.00K 10-K · filed 2017-12-12 | ||||||||||||
| 2015-06-30 | $123.75K 10-K · filed 2016-12-14 | $167.50K derived: sum of 2 quarters · filed 2016-12-14 | $338.25K 10-Q · filed 2016-08-09 | $382.00K derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||
| 2015-03-31 | $43.75K 10-K · filed 2016-12-14 | $214.50K 10-Q · filed 2016-05-10 | $258.25K derived: sum of 3 quarters · filed 2016-12-14 | $302.00K derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||
| 2014-12-31 | $170.75K 10-K · filed 2016-12-14 | $214.50K derived: sum of 2 quarters · filed 2016-12-14 | $258.25K derived: sum of 3 quarters · filed 2016-12-14 | $302.00K derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||
| 2014-09-30 | $43.75K 10-K · filed 2015-12-14 | $87.50K derived: sum of 2 quarters · filed 2015-12-14 | $131.25K derived: sum of 3 quarters · filed 2015-12-14 | $175.00K 10-K · filed 2016-12-14 | ||||||||||||
| 2014-06-30 | $43.75K 10-K · filed 2015-12-14 | $87.50K derived: sum of 2 quarters · filed 2015-12-14 | $131.25K 10-Q · filed 2015-08-04 | $175.00K derived: sum of 4 quarters · filed 2015-12-14 | ||||||||||||
| 2014-03-31 | $43.75K 10-K · filed 2015-12-14 | $87.50K 10-Q · filed 2015-05-11 | $131.25K derived: sum of 3 quarters · filed 2015-12-14 | $175.00K derived: sum of 4 quarters · filed 2015-12-14 | $4.52M 10-Q · filed 2014-05-06 | |||||||||||
| 2013-12-31 | $43.75K 10-K · filed 2015-12-14 | $87.50K derived: sum of 2 quarters · filed 2015-12-14 | $131.25K derived: sum of 3 quarters · filed 2015-12-14 | $175.00K derived: sum of 4 quarters · filed 2015-12-14 | $4.47M 10-Q · filed 2014-02-04 | |||||||||||
| 2013-09-30 | $43.75K 10-K · filed 2014-11-25 | $87.50K derived: sum of 2 quarters · filed 2014-11-25 | $131.25K derived: sum of 3 quarters · filed 2014-11-25 | $290.27K 10-K · filed 2015-12-14 | $4.43M 10-K · filed 2013-12-18 | |||||||||||
| 2013-06-30 | $43.75K 10-K · filed 2014-11-25 | $87.50K derived: sum of 2 quarters · filed 2014-11-25 | $246.52K 10-Q · filed 2014-08-12 | $290.27K derived: sum of 4 quarters · filed 2014-11-25 | $4.39M 10-Q · filed 2013-08-07 | |||||||||||
| 2013-03-31 | $43.75K 10-K · filed 2014-11-25 | $202.77K 10-Q · filed 2014-05-06 | $246.52K derived: sum of 3 quarters · filed 2014-11-25 | $294.43K derived: sum of 4 quarters · filed 2014-11-25 | $4.34M 10-Q · filed 2013-05-09 | |||||||||||
| 2012-12-31 | $159.02K 10-K · filed 2014-11-25 | $202.77K derived: sum of 2 quarters · filed 2014-11-25 | $250.68K derived: sum of 3 quarters · filed 2014-11-25 | $281.93K derived: sum of 4 quarters · filed 2014-11-25 | $4.30M 10-Q · filed 2013-02-13 | |||||||||||
| 2012-09-30 | $43.75K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-25 | $91.67K derived: sum of 2 quarters · filed 2014-11-25 | $122.92K derived: sum of 3 quarters · filed 2014-11-25 | $146.88K 10-K · filed 2014-11-25 | $4.14M 10-K · filed 2012-12-28 | |||||||||||
| 2012-06-30 | $47.92K 10-Q · filed 2013-08-07 | $79.17K derived: sum of 2 quarters · filed 2013-08-07 | $103.13K 10-Q · filed 2013-08-07 | $103.13K derived: sum of 4 quarters · filed 2013-08-07 | $4.10M 10-Q · filed 2012-08-13 | |||||||||||
| 2012-03-31 | $31.25K 10-Q · filed 2013-05-09 | $55.21K 10-Q · filed 2013-05-09 | $55.21K derived: sum of 3 quarters · filed 2013-05-09 | $55.21K derived: sum of 4 quarters · filed 2013-05-09 | $4.05M 10-Q · filed 2012-05-08 | |||||||||||
| 2011-12-31 | $23.96K 10-Q · filed 2013-02-13 | $23.96K derived: sum of 2 quarters · filed 2013-02-13 | $23.96K derived: sum of 3 quarters · filed 2013-02-13 | $23.96K derived: sum of 4 quarters · filed 2013-02-13 | $4.02M 10-Q · filed 2012-02-09 | |||||||||||
| 2011-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-28 | $0.00 derived: sum of 2 quarters · filed 2012-12-28 | $0.00 derived: sum of 3 quarters · filed 2012-12-28 | $296.14K 10-K · filed 2012-12-28 | $3.99M 10-K · filed 2011-12-20 | |||||||||||
| 2011-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-13 | $0.00 derived: sum of 2 quarters · filed 2012-08-13 | $296.14K 10-Q · filed 2012-08-13 | $3.99M 10-Q · filed 2011-08-08 | ||||||||||||
| 2011-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-08 | $296.14K 10-Q · filed 2012-05-08 | ||||||||||||||
| 2010-12-31 | $296.14K 10-Q · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |